Deacetylation of phosphoglycerate mutase in its distinct central region by SIRT2 down-regulates its enzymatic activity

Genes to Cells

Volumn 19, Issue 10, 2014, Pages 766-777

  Tsusaka, Takeshi ^a   Guo, Tingting ^a   Yagura, Teiti ^a   Inoue, Toshiaki ^b   Yokode, Masayuki ^c   Inagaki, Nobuya ^a   Kondoh, Hiroshi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HISTONE ACETYLTRANSFERASE PCAF; LYSINE; P300-CBP-ASSOCIATED FACTOR; PHOSPHOGLYCERATE MUTASE; SIRT2 PROTEIN, HUMAN; SIRTUIN; SIRTUIN 2;

ACETYLATION; ANIMAL; CELL PROLIFERATION; DOWN REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; MUTATION; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ACETYLATION; ANIMALS; ARGININE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; LYSINE; MICE; MUTATION; P300-CBP TRANSCRIPTION FACTORS; PHOSPHOGLYCERATE MUTASE; PROTEIN STRUCTURE, TERTIARY; SIRTUIN 2; SIRTUINS;

EID: 84908243726     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12176     Document Type: Article

References (27)

1. Brummelkamp, T.R., Bernards, R. & Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553.
2. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M.L., Rehman, M., Walther, T.C., Olsen, J.V. & Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840.
3. Durany, N., Joseph, J., Campo, E., Molina, R. & Carreras, J. (1997) Phosphoglycerate mutase, 2, 3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas. Br. J. Cancer 75, 969-977.
4. Evans, M.J., Saghatelian, A., Sorensen, E.J. & Cravatt, B.F. (2005) Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling. Nat. Biotechnol. 23, 1303-1307.
5. Hallows, W.C., Yu, W. & Denu, J.M. (2012) Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation. J. Biol. Chem. 287, 3850-3858.
6. Hebert, A.S., Dittenhafer-Reed, K.E., Yu, W. et al. (2013) Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49, 186-199.
7. Hiratsuka, M., Inoue, T., Toda, T., Kimura, N., Shirayoshi, Y., Kamitani, H., Watanabe, T., Ohama, E., Tahimic, C.G., Kurimasa, A. & Oshimura, M. (2003) Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem. Biophys. Res. Commun. 309, 558-566.
8. Hitosugi, T., Zhou, L., Elf, S. et al. (2012) Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell 22, 585-600.
9. Hitosugi, T., Zhou, L., Fan, J. et al. (2013) Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation. Nat. Commun. 4, 1790.
10. Iyer, N.V., Kotch, L.E., Agani, F., Leung, S.W., Laughner, E., Wenger, R.H., Gassmann, M., Gearhart, J.D., Lawler, A.M., Yu, A.Y. & Semenza, G.L. (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1alpha. Genes Dev. 12, 149-162.
11. Jeong, S.M., Xiao, C., Finley, L.W. et al. (2013) SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23, 450-463.
12. Kim, H.S., Patel, K., Muldoon-Jacobs, K. et al. (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17, 41-52.
13. Kim, H.S., Vassilopoulos, A., Wang, R.H. et al. (2011) SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell 20, 487-499.
14. Kim, S.C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., Grishin, N.V., White, M., Yang, X.J. & Zhao, Y. (2006) Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23, 607-618.
15. Kondoh, H., Lleonart, M.E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A. & Beach, D. (2005) Glycolytic enzymes can modulate cellular life span. Cancer Res. 65, 177-185.
16. Lin, R., Tao, R., Gao, X., Li, T., Zhou, X., Guan, K.L., Xiong, Y. & Lei, Q.Y. (2013) Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol. Cell 51, 506-518.
17. Mikawa, T., Maruyama, T., Okamoto, K., Nakagama, H., Lleonart, M.E., Tsusaka, T., Hori, K., Murakami, I., Izumi, T., Takaori-Kondo, A., Yokode, M., Peters, G., Beach, D. & Kondoh, H. (2014) Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2. J. Cell Biol. 204, 729-745.
18. Ren, F., Wu, H., Lei, Y., Zhang, H., Liu, R., Zhao, Y., Chen, X., Zeng, D., Tong, A., Chen, L., Wei, Y. & Huang, C. (2010) Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma. Mol. Cancer 9, 81.
19. Roth, S.Y., Denu, J.M. & Allis, C.D. (2001) Histone acetyltransferases. Annu. Rev. Biochem. 70, 81-120.
20. Sebastian, C., Zwaans, B.M., Silberman, D.M. et al. (2012) The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151, 1185-1199.
21. Seo, K.S., Park, J.H., Heo, J.Y., Jing, K., Han, J., Min, K.N., Kim, C., Koh, G.Y., Lim, K., Kang, G.Y., Uee Lee, J., Yim, Y.H., Shong, M., Kwak, T.H. & Kweon, G.R. (2014) SIRT2 regulates tumour hypoxia response by promoting HIF-1alpha hydroxylation. Oncogene doi: 10.1038/onc.2014.76.
22. Serrano, L., Martinez-Redondo, P., Marazuela-Duque, A., Vazquez, B.N., Dooley, S.J., Voigt, P., Beck, D.B., Kane-Goldsmith, N., Tong, Q., Rabanal, R.M., Fondevila, D., Munoz, P., Kruger, M., Tischfield, J.A. & Vaquero, A. (2013) The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes Dev. 27, 639-653.
23. Shalom-Barak, T. & Knaus, U.G. (2002) A p21-activated kinase-controlled metabolic switch up-regulates phagocyte NADPH oxidase. J. Biol. Chem. 277, 40659-40665.
24. Vander Heiden, M.G., Locasale, J.W., Swanson, K.D., Sharfi, H., Heffron, G.J., Amador-Noguez, D., Christofk, H.R., Wagner, G., Rabinowitz, J.D., Asara, J.M. & Cantley, L.C. (2010) Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329, 1492-1499.
25. Warburg, O. (1956) On respiratory impairment in cancer cells. Science 124, 269-270.
26. Zhao, D., Zou, S.W., Liu, Y., Zhou, X., Mo, Y., Wang, P., Xu, Y.H., Dong, B., Xiong, Y., Lei, Q.Y. & Guan, K.L. (2013) Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Cancer Cell 23, 464-476.
27. Zhao, S., Xu, W., Jiang, W. et al. (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-1004.